### Perinatal Substance Use Disorders Research

- [ Research Projects](#research-projects)
 
  Our research focuses on substance use disorders (SUDs) in pregnancy and substance-exposed newborns. Specifically, we are conducting trials related to pharmacologic treatments for opioid use disorder in pregnancy; cannabis use disorders in pregnancy; placental biomarkers; genetics; pharmacokinetics; fetal alcohol spectrum disorders (FASD); and the long-term childhood outcomes of substance exposure in utero.

[Explore All Pediatric Research Programs](/node/178218 "Department of Pediatrics: Pediatric Specialty Care: Pediatric Research | Boston Medical Center (bmc.org)")

## Our Team

![BMC Substance Use Disorder (SUD) in Pregnancy group photo](/sites/default/files/inline-images/SUD%20Pregnancy%20Photo%20Original_0.jpg)### Contact

- **Principal Investigator**  
    Elisha M. Wachman  
    <Elisha.Wachman@bmc.org>
- **Project Manager**  
    Chloe Deflorimonte  
    <Chloe.Deflorimonte@bmc.org>

### Investigators

**Department of Pediatrics**

- [Elisha M. Wachman, MD](https://profiles.bu.edu/Elisha.Wachman)
- [Vincent C. Smith, MD, MPH](https://profiles.bu.edu/Vincent.Smith)
- [Mei A. Elansary, MD, MPhil](https://profiles.bu.edu/Mei.Elansary)
- [Mark H. Mirochnick, MD](https://profiles.bu.edu/Mark.Mirochnick)

**Department of Obstetrics &amp; Gynecology**

- [Kelley Anne Saia, MD](https://profiles.bu.edu/Kelley.Saia)
- [Erica Holland, MD](https://profiles.bu.edu/Erica.Holland)



 ## Research Projects

1. Promoting positive parenting for mothers with OUD: Implementation of a video-coaching intervention in pediatrics (NIH 1K23DA061933)
2. [Boston University Women’s Health Research Affinity Research Collaborative](https://www.bumc.bu.edu/evanscenteribr/2024/08/07/boston-university-womens-health-arc/)
3. [Boston University BIRCWH Program](https://www.bu.edu/ctsi/training-education/boston-university-bircwh-program/) (NIH 1K12AR085635)
4. NICU Withdrawal Assessment Scale (Gerber Foundation) CTN-0080 Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMS) Randomized Clinical Trial (UG1DA013732), NCT03918850
5. [MAT-LINK](https://www.cdc.gov/mat-link/about/) (Maternal and Infant Network to Understand Outcomes Associated with Medication for Opioid Use Disorder in Pregnancy)
6. POD (Placental Markers of Opioid Use Disorder on Development) Study (R01HD113143)
7. The First Year Study: A Prospective Mixed Methods Study of Maternal and Child Well-being and Risk of Relapse in the First Year Postpartum (BU CTSI)
8. [SAFEST Choice National Learning Collaborative](https://safestchoice.org/)
9. [American Academy of Pediatrics FASD Toolkit](https://www.aap.org/en/patient-care/fetal-alcohol-spectrum-disorders/)
10. Naltrexone for Cannabis Use Disorder in Pregnancy (BU CTSI)